BioGenex® – Reliable and Sensitive COVID-19 RT-PCR Direct, COVID-19 B.1.1.7 Variant RT-PCR and Influenza SARS-CoV-2 (Flu SC2) Multiplex RT-PCR Assays for Research Use Only (RUO)

BioGenex® SARS-CoV-2 RT-PCR Direct Assay (RUO)

  • As described in the kit insert, COVID-19 RT-PCR Direct is a real-time reverse transcription polymerase chain reaction (RT-PCR) test that analyzes nasopharyngeal samples in VTM directly without the need for RNA extraction step.
  • Assays target two specific genomic regions of SARS-CoV-2: the nucleocapsid (N1 and N2) genes and another one primer and probe set to detect human RNase P (RP) in a sample.
  • Specific: Detection of SARS-CoV-2 the nucleocapsid (N1 and N2) genes
  • Sensitive: Limit of detection of 7.25 copies/uL
  • Flexible: Compatible with a variety of sample types.
  • Reliable: Performance confirmed and verified with case studies from outbreak’s Point of origin.
  • Turn around time: Lesser than usual RT-PCR since No RNA Extraction from the sample.

BioGenex® Influenza SARS-CoV-2 (Flu SC2) RT-PCR Assay (RUO)

  • Influenza SARS-CoV-2 (Flu SC2) RT-PCR Assay is a molecular in vitro test that aids in the detection and differentiation of influenza A virus, influenza B virus or/and SARS-CoV-2 and is based on widely used nucleic acid amplification technology.
  • In this test, three primer and probe sets aid to detect one specific regions of the Influenza A {Matrix, (M1) gene}, Influenza B {Nonstructural 2 (NS2) gene}, and Covid-19 (N gene) and one primer and probe set to detect human RNase P in a test sample.
  • Specific: Detection and differentiation of RNA from influenza A virus, influenza B virus or/and SARS-CoV-2.
  • Sensitive: Limit of detection (LoD)of 25 copies/uL.
  • Flexible: Compatible with a variety of sample types.
  • Reliable: Performance confirmed and verified with case studies from outbreak’s point of origin.

BioGenex® B117 RT-PCR Assay(RUO)

  • As described in the kit insert, The B117 RT-PCR Assay (UK Variant included) is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasal swab from individuals suspected of COVID-19.
  • Assay aid to qualitative detection of SRAS-CoV-2 wild type and UK variant virus RNA directly (without RNA extraction) from nasal swab collected in commercially available Viral Transport Media (VTM).
  • Oligonucleotide primers hybridize to specific nucleotide sequences of the UK Variant SARS-CoV-2 (B.1.1.7) N (D3L mutant) gene and RdRp gene of SARS-CoV-2 (both wild type and B.1.1.7 variant).
  • B117 RT-PCR is compatible with real time PCR instruments with FAM, HEX, RED/Cy-5 channels.
  • Specific: Detection of SARS-CoV-2 B.1.1.7 Variant.
  • Sensitive: Limit of detection of 50 copies/uL
  • Flexible: Compatible with a variety of sample types.
  • Reliable: Performance confirmed and verified with case studies from outbreak’s Point of origin.
  • Turnaround time: Lesser than usual RT-PCR since No RNA Extraction from the sample.